TB REACH Tanzania

In Tanzania, the population of workers involved in the mining sector is a high-risk group for TB. This is especially true for individuals involved in small-scale (artisanal/informal) mining communities where persons are living in poorly ventilated, crowded mining camps, work underground in small, dusty spaces, and do not have access to the company-employed TB doctors typical in the large-scale mining industry. These small-scale miners are particularly mobile, as gold rushes are common, and miners move often between different mining camps. Furthermore, these mobile mining populations often lack the built-in community support associated with rooted family support systems. The TB REACH project in Tanzania introduces 99DOTS as a Digital Adherence Technology (DAT) in the gold mining Geita region in northwestern Tanzania to enable treatment and adherence support for miners with Drug Resistant Tuberculosis (DS-TB).

Since 2018, KNCV has rolled-out DAT demonstration projects in three countries – Philippines, Tanzania and Ukraine-, funded by the Stop TB Partnership, TB REACH. The goal of these demonstration project is to assess the feasibility, acceptability by patients and health care providers, and the accuracy of digital adherence technologies. In addition, the project will assess the overall impact of DATs on treatment outcomes and general adherence behavior. As part of the project, KNCV will determine the necessary adaptations needed to make DATs suitable for a variety of contexts, including how to incorporate patient-centered mechanisms, and steps to scale-up and sustain these innovative approaches.

Project highlights

  • Over 790 patients registered on the DAT platform
  • Surveys from over 170 patients and health care workers on the acceptability and feasibility of DATs in Tanzania
  • Patients empowered with insights into their treatment adherence to better support themselves
  • Custom adaptations to the sleeves for usability in Tanzania that can be replicated across other products.

One of the main benefits of DATS is the availability of electronically compiled dosing histories which can be used to efficiently guide individualized patient centered care. To support the current DOT standard of care in Tanzania, which is (>90% of patients) self-administrated home-based treatment, the adherence platform is customized to send SMS reminders to patients who have not taken their daily medication by 6pm. Where patients have missed two or three consecutive daily doses of medication, the DAT prioritizes these patients and sends an SMS reminder to the health care provider to call or visit these patients at home, to counsel and motivate patients to take their medication.

This technology driven intervention has empowered patients and supported health care workers to improve the current DS-TB regimen performance by closing gaps in treatment (half of the cascade of care).

DATs can play an important role to reinforce patient medication adherence and facilitate monitoring and triage of patients by health systems, this can include customized motivational and educational messages based on patient dosing histories for patients who need more support.

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Annual Report Summary 2019
KNCV 2-pager ASCENT
KNCV 2-pager Childhood TB
KNCV 2-pager Digital Health
KNCV 2-pager General
KNCV 2pager Right Diagnosis, Right Treatment
KNCV 2-pager TB Photovoices
KNCV 2-pager TB Stigma

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.